Hepatitis C virus inhibitors
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Bristol-Myers Squibb Company
C C C A A A C C C
C07D C07D C07D A61P A61P A61P C07D C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional
Jayne Andrew C. Yuping Michael Jeffrey Lee Omar D. Guo Fukang Denis R. Jason Lawrence B. Ramesh Van N. Makonen
Kapur Good Qiu Serrano-Wu Romine Lopez Li Yang St. Laurent Goodrich Snyder Kakarla Nguyen Belema